1016778-99-6Relevant articles and documents
Protein kinase inhibitor and its composition and use thereof
-
Paragraph 0219-0221; 0256-0258, (2017/08/02)
The invention relates to compounds as shown in the general formula (I), pharmaceutical compositions containing the compounds, a method for treating diseases and disease symptoms related to abnormal activity of protein kinase by using the compounds, and medicinal use of the compounds.
HETEROCYCLIC SULFONAMIDES AS RAF INHIBITORS
-
Page/Page column 63, (2012/09/21)
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.